Sweden
Related tags
Breast Cancer Indication
Herceptin® therapy has now become a standard of care for HER2-overexpressing metastatic breast cancer, and a pharmDx™ test for HER2 protein overexpression or HER2 gene amplification is conducted to assess Herceptin® eligibility.
Leading pathologists endorse and use HercepTest™: See and hear why!
Dako Breast Cancer Literature
Dako provides a variety of material for HER2 testing in Breast Cancer.
Would you like further information? Please contact your local Dako representative for additional material.
HercepTest™ material:
HercepTest™ Interpretation Manual - Breast IHC
(Literature Order No.: 28630)
HercepTest™ Brochure
(Literature Order No.: 28633)
HercepTest™ Scoring Guidelines - Breast IHC
(Literature Order No.: 38602)
FISH material:
HER2 FISH pharmDx™ - Step by Step Procedure
(Literature Order No.: 00197)
HER2 FISH pharmDx™ Interpretation Guide Breast
(Literature Order No.: 00198)
HER2 FISH pharmDx™ Assay Kit Brochure
(Literature Order No.: 00195)
CISH material:
HER2 CISH pharmDx™ Interpretation Guide - Breast
(Literature Order No.: 29023)
HER2 CISH pharmDx™ - Step by Step Procedure
(Literature Order No.: 38651)
HER2 CISH pharmDx™ - Bright Field Convenience
(Literature Order No.: 38661)